CYTOKINETICS, INCORPORATED |
Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
| 48.4 EUR | -1.22% |
|
+1.24% | -34.05% |
| 06-24 | JPMorgan Cuts Price Target on Cytokinetics to $65 From $77, Maintains Overweight Rating | MT |
| 06-17 | Cytokinetics Insider Sold Shares Worth $262,750, According to a Recent SEC Filing | MT |
eba.QtPmQgEbre93pZGqWRF3Zs62WhjCabQOyCzx1m-clEA.Or6UDnR1xYJG58nMF0gcB7_hbV6uCPpYp2_JvV3vogh6prB3eVP9px_L_g~3bcff772d50c125fd60eeacb10ab8a84
